BSI-045B

· Biosion, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BSI-045B, covering 2025-09-19 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis [Phase 2]